Year-over-year, this metric grew by 23.2%, from $446.29M to $549.93M. Over 4 years (FY 2021 to FY 2025), Share Buybacks shows a downward trend with a -17.2% CAGR.
High repurchases often signal management's confidence in the company's valuation or a strategy to improve earnings per share.
The cash outflow associated with the company buying back its own shares from the open market. This is a primary method f...
Common among mature, cash-generative companies; peers in the healthcare sector often balance this with R&D investment.
share_repurchases| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $269.98M | $760.76M | $699.94M | $649.65M | $600.34M | $889.74M | $781.58M | $202.79M | $215.49M | $0.00 | $1.00K | $800.05M | $100.00M | $0.00 | $651.90M | $446.29M | $244.80M | $500.00M | $0.00 | $549.93M |
| QoQ Change | — | +181.8% | -8.0% | -7.2% | -7.6% | +48.2% | -12.2% | -74.1% | +6.3% | -100.0% | — | >999% | -87.5% | -100.0% | — | -31.5% | -45.1% | +104.2% | -100.0% | — |
| YoY Change | — | — | — | — | +122.4% | +17.0% | +11.7% | -68.8% | -64.1% | -100.0% | -100.0% | +294.5% | -53.6% | — | >999% | -44.2% | +144.8% | — | -100.0% | +23.2% |